Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCSW) Return on Equity (2022 - 2025)

Historic Return on Equity for HeartSciences (HSCSW) over the last 4 years, with Q4 2025 value amounting to 2.48%.

  • HeartSciences' Return on Equity fell 9200.0% to 2.48% in Q4 2025 from the same period last year, while for Oct 2025 it was 2.48%, marking a year-over-year decrease of 9200.0%. This contributed to the annual value of 2.35% for FY2025, which is 5900.0% down from last year.
  • Per HeartSciences' latest filing, its Return on Equity stood at 2.48% for Q4 2025, which was down 9200.0% from 5.27% recorded in Q3 2025.
  • In the past 5 years, HeartSciences' Return on Equity registered a high of 464.71% during Q2 2023, and its lowest value of 16.44% during Q1 2023.
  • In the last 4 years, HeartSciences' Return on Equity had a median value of 1.69% in 2024 and averaged 33.7%.
  • Its Return on Equity has fluctuated over the past 5 years, first soared by 387900bps in 2023, then tumbled by -4655500bps in 2024.
  • Over the past 4 years, HeartSciences' Return on Equity (Quarter) stood at 3.35% in 2022, then surged by 267bps to 5.61% in 2023, then tumbled by -128bps to 1.56% in 2024, then tumbled by -59bps to 2.48% in 2025.
  • Its last three reported values are 2.48% in Q4 2025, 5.27% for Q3 2025, and 8.89% during Q2 2025.